Stay updated on Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:27:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the generic government funding/operating status notice from the page. This change does not modify the study details, eligibility criteria, or outcomes.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the study page; core details and status appear unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T21:20:49.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a new label 'Last Update Posted (Estimated)' while removing 'Last Update Posted'. This is a minor metadata wording change and does not affect core content, pricing, stock, or time-sensitive information.
    Difference
    0.0%
    Check dated 2025-10-13T09:33:18.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Updated operating-status notice and new date/version metadata; older dates and the previous revision tag were removed. The page now reflects current status guidance and a newer revision/version (v3.2.0).
    Difference
    4%
    Check dated 2025-10-06T05:59:12.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Upgrade applied: version bumped from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T03:12:52.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.